Secondary neoplasms in mycosis fungoides: evaluating risk factors and phototherapy impact in a comparative study
Open Access
- 17 June 2025
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 104 (7) , 3829-3836
Abstract
Patients with mycosis fungoides (MF) are at an increased risk of developing secondary neoplasms. We conducted a comparative analysis between MF patients with and without secondary neoplasms and non-MF patients to assess secondary neoplasm occurrence and identify potential risk factors. We aimed to evaluate the prevalence of secondary neoplasms and investigate associated risk factors in MF patients. Demographic data, treatments, phototherapy details, neoplasm occurrence and detection time, and mortality rates were collected and retrospectively analyzed for 252 MF and 278 control patients. The prevalence of secondary neoplasms was significantly higher in the MF group (13.9%) compared to the control group (3.6%) ( p < 0.001). MF patients with neoplasms had a higher average age and older age at MF diagnosis ( p = 0.003 and 0.016, respectively). Phototherapy type showed no significant association with neoplasm presence. Elevated initial and final beta-2 microglobulin levels were observed in MF patients with neoplasms ( p = 0.002 and 0.005, respectively). MF patients have a higher risk of developing secondary neoplasms compared to controls. Risk increases with older age at MF diagnosis and elevated beta-2 microglobulin levels. Phototherapy was not associated with the development of secondary neoplasms in MF patients. MF patients with secondary neoplasms exhibit higher mortality rates, underscoring the importance of early detection and vigilant monitoring.Keywords
Funding Information
- Ege Üniversitesi
This publication has 15 references indexed in Scilit:
- Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancerJournal of the American Academy of Dermatology, 2021
- Screening for second malignancies in mycosis fungoides: non‐Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanomaJournal of the European Academy of Dermatology and Venereology, 2021
- Importance of diagnostics and risk of secondary malignancies in primary cutaneous lymphomasJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2021
- Melanoma Risk is Increased in Patients with Mycosis Fungoides Compared with Patients with Psoriasis and the General Population*Acta Dermato-Venereologica, 2020
- Mycosis fungoides associated with recurrence of malignant melanomaJAAD Case Reports, 2020
- Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfallsAnnals of Diagnostic Pathology, 2020
- Gender differences in the risk of secondary malignancies in patients with mycosis fungoides and Sézary syndromeJournal of the American Academy of Dermatology, 2020
- Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysisJournal of the American Academy of Dermatology, 2020
- Increased risk of second primary malignancies in patients with mycosis fungoides: A single-center cohort studyJournal of the American Academy of Dermatology, 2020
- Risk of second malignancy after cutaneous T-cell lymphomaCancer, 1989